Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fusion Pharmaceuticals (FUSN)
NASDAQ:FUSN
RESEARCH TOOLSreports
Fusion Pharmaceuticals (FUSN) Stock Price & Analysis
350 Followers
FUSN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.31 - $21.55
Previous Close$21.31
Volume862.59K
Average Volume (3M)2.24M
Market Cap
$1.81B
Enterprise Value$1.62B
Total Cash (Recent Filing)$233.61M
Total Debt (Recent Filing)$50.56M
Price to Earnings (P/E)-14.5
Beta0.92
Next Earnings
May 07, 2024EPS Estimate
-$0.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.47
Shares Outstanding84,692,585
10 Day Avg. Volume1,690,486
30 Day Avg. Volume2,242,148
Standard Deviation0.29
R-Squared0.02
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)8.11
Price to Sales (P/S)872.73
Price to Cash Flow (P/CF)-25.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue784.21
Enterprise Value/Gross Profit784.21
Enterprise Value/Ebitda-18.51
Forecast
1Y Price Target
$20.94Price Target Upside-1.60% Downside
Rating ConsensusHold
Number of Analyst Covering13
Fusion Pharmaceuticals News
Ownership Overview
28.25% Insiders
8.89% Mutual Funds
1.22% Other Institutional Investors
61.63% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
FUSN FAQ
What was Fusion Pharmaceuticals’s price range in the past 12 months?
Fusion Pharmaceuticals lowest stock price was $2.31 and its highest was $21.55 in the past 12 months.
What is Fusion Pharmaceuticals’s market cap?
Currently, no data Available
When is Fusion Pharmaceuticals’s upcoming earnings report date?
Fusion Pharmaceuticals’s upcoming earnings report date is May 07, 2024 which is in 18 days.
How were Fusion Pharmaceuticals’s earnings last quarter?
Fusion Pharmaceuticals released its earnings results on Mar 20, 2024. The company reported -$0.39 earnings per share for the quarter, missing the consensus estimate of -$0.339 by -$0.051.
Is Fusion Pharmaceuticals overvalued?
According to Wall Street analysts Fusion Pharmaceuticals’s price is currently Overvalued.
Does Fusion Pharmaceuticals pay dividends?
Fusion Pharmaceuticals does not currently pay dividends.
What is Fusion Pharmaceuticals’s EPS estimate?
Fusion Pharmaceuticals’s EPS estimate is -$0.37.
How many shares outstanding does Fusion Pharmaceuticals have?
Fusion Pharmaceuticals has 84,692,590 shares outstanding.
What happened to Fusion Pharmaceuticals’s price movement after its last earnings report?
Fusion Pharmaceuticals reported an EPS of -$0.39 in its last earnings report, missing expectations of -$0.339. Following the earnings report the stock price went up 0.522%.
Which hedge fund is a major shareholder of Fusion Pharmaceuticals?
Among the largest hedge funds holding Fusion Pharmaceuticals’s share is Deerfield Management Company, LP. It holds Fusion Pharmaceuticals’s shares valued at 62M.
---
Fusion Pharmaceuticals Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$20.94 (-1.60% Downside)
$20.94 (-1.60% Downside)
Blogger Sentiment
Bullish
FUSN Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 3.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.1%
Last 30 Days ▼ 14.7%
Last 30 Days ▼ 14.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
411.03%
12-Months-Change
Fundamentals
Return on Equity
-49.34%
Trailing 12-Months
Asset Growth
30.48%
Trailing 12-Months
Company Description
Fusion Pharmaceuticals
Fusion Pharmaceuticals Inc is a clinical stage bio-pharmaceutical company focused on developing alpha therapeutics for curing cancer.
---
FUSN Stock 12 Months Forecast
Average Price Target
$20.94
▼(-1.60% Downside)
Technical Analysis
Best Analysts Covering FUSN
1 Year
1 Year Success Rate
4/4 ratings generated profit
1 Year Average Return
+278.05%
reiterated a buy rating last month
Copying Jeff Jones's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +278.05% per trade.
---